Steady-State Versus Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma: A Single-Center Study to Analyze Efficacy and Safety [0.03%]
稳定状态与化疗基于的干细胞动员在多发性骨髓瘤中的疗效和安全性的单一中心研究
Nora Obajed Al-Ali,Laszlo Imre Pinczes,Katalin Farkas et al.
Nora Obajed Al-Ali et al.
Background: High-dose chemotherapy followed by autologous hematopoietic stem cell support is recommended in the treatment of eligible multiple myeloma (MM) patients. The aim of this study was to compare the efficacy and s...
Unraveling the Rare Entity of KIT D816V-Negative Systemic Mastocytosis [0.03%]
揭秘KIT D816V阴性全身性mastocytosis罕见病例
Ruah Alyamany,Chams Alkhalaf Albachir,Sarah Alsaleh et al.
Ruah Alyamany et al.
Systemic mastocytosis (SM) is a rare type of myeloproliferative neoplasm characterized by abnormal proliferation and infiltration of different tissue by clonal mast cells. The uncontrolled proliferation and activation of mast cells trigger ...
Case Reports
Journal of hematology. 2024 Jun;13(3):128-136. DOI:10.14740/jh1279 2024
A Unique Case of a Compound Heterozygosity of Hemoglobin Korle-Bu and Sickle Cell Trait in a Military Trainee [0.03%]
一名军事训练员同时患有科勒-布型血红蛋白和镰状细胞特质的罕见病例报告
Gartrell C Bowling,Niels A Ryden,Allen R Holmes et al.
Gartrell C Bowling et al.
Hemoglobin Korle-Bu (Hb KB) is a rare and likely under-reported hemoglobin (Hb) variant resulting from an unusual point mutation on the beta-globin chain. Hb KB is typically clinically silent, and there are limited reports of Hb KB heterozy...
Case Reports
Journal of hematology. 2024 Jun;13(3):116-120. DOI:10.14740/jh1257 2024
Fat Embolism Syndrome Mimicking Thrombotic Thrombocytopenic Purpura in a Patient With Hemoglobin S/Beta-Thalassemia [0.03%]
一名HbS/β-地中海贫血患者发生模仿血栓性血小板减少性紫癜的脂肪栓塞综合征
Bobby Se,Austin Frisch,Min Woo Hwang et al.
Bobby Se et al.
Thrombotic microangiopathies cause ischemic organ damage and require urgent management for a favorable prognosis. Fat embolism syndrome from bone marrow necrosis is a rare and unique pathology that carries a high mortality rate. It can mimi...
Case Reports
Journal of hematology. 2024 Jun;13(3):104-107. DOI:10.14740/jh1274 2024
Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia [0.03%]
一例溶血性贫血的诊治体会
Fulvio Castelgrande,Gemma Viola,Cinzia Calabrese et al.
Fulvio Castelgrande et al.
Thalassemic diseases are characterized by a reduced (β+) or absent (β0) synthesis of the globin chains of hemoglobin (Hb) due to genetic mutations. β-thalassemia was more frequent in the Mediterranean area, but now it is diffused worldwi...
Case Reports
Journal of hematology. 2024 Jun;13(3):108-115. DOI:10.14740/jh1204 2024
Predictors of Non-Variceal Hemorrhage in a National Cohort of Patients With Chronic Liver Disease [0.03%]
慢性肝病患者全国队列非曲张静脉出血的预测因素
Amber Afzal,Preethi Kesavan,Luo Suhong et al.
Amber Afzal et al.
Background: Non-variceal hemorrhage in patients with chronic liver disease (CLD) increases morbidity, mortality, and healthcare costs. There are limited data on risk factors for non-variceal hemorrhage in the CLD populati...
Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity [0.03%]
肝脾T细胞淋巴瘤：一个具有挑战性的诊断实体
Abanoub Gabra,Joanna Polanco,Shrija Thapa et al.
Abanoub Gabra et al.
Hepatosplenic T-cell lymphoma (HSTCL) is rare and clinically very aggressive T-cell lymphoma. The majority of cases harbor γδ T-cell receptors (TCRs); however, in some even rarer cases, tumor cells harbor αβ TCR. Recent studies suggest ...
Case Reports
Journal of hematology. 2024 Apr;13(1-2):29-33. DOI:10.14740/jh1203 2024
Natural Anticoagulant Protein Levels in Patients With Beta-Thalassemia Major: A Case-Control Study [0.03%]
重型β地中海贫血患者中天然抗凝蛋白水平的病例对照研究
Abbas Ahmadi,Soudabeh Hosseini,Akbar Dorgalaleh et al.
Abbas Ahmadi et al.
Background: β-thalassemia is a group of inherited blood disorders that affect the production of β-globin chains, leading to the reduction or absence of these chains. One of the complications observed in patients with β...
Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant Recipient [0.03%]
嵌合抗原受体T细胞治疗成功治愈1例难治性心脏移植后淋巴增殖性疾病患者
Katherine Hickmann,Ryan Sweeney,Chelsea Peterson et al.
Katherine Hickmann et al.
Post-transplant lymphoproliferative disorders (PTLDs) are opportunistic malignancies that complicate the success of hematopoietic stem cell or solid organ transplantation. These disorders often arise post-transplant due to the immunosuppres...
Case Reports
Journal of hematology. 2024 Apr;13(1-2):34-38. DOI:10.14740/jh1211 2024
Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis [0.03%]
程序性死亡配体1抗体治疗噬血细胞综合征型外周T/NK细胞淋巴瘤的疗效分析
Chun Li Yang,Xi Chen,Hui Jie Zhou et al.
Chun Li Yang et al.
Extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis (ENKTCL-LAHS) is a rare disease with poor prognosis. Currently, there are no well-established treatments for LAHS. Almost 50% of patients experience rel...
Case Reports
Journal of hematology. 2024 Apr;13(1-2):46-51. DOI:10.14740/jh1242 2024